IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates

IGC Pharma, Inc. (IGC) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of$ 0.03. This compares to a loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +33.33%. A quarter ago, it was expected that this company would post a loss of$ 0.02 per share when it actually produced a loss of $0.01, delivering a surprise of +50%.Over the last four quarters, the company has surpass ...